Some people searching research peptides want to know whether they can use them on themselves. Research-use-only peptides are labeled for laboratory research, not for human or veterinary use. No research-grade product is FDA-approved for use in people. This page sets out the risks FDA, CDC and others have documented, and what to do if something goes wrong. It gives no instructions of any kind. Sources were checked on November 17, 2026.
Quick answer: Research-use-only peptides are not meant to be used in people, and none is FDA-approved for human use. FDA describes risks that include unknown quality, wrong or harmful ingredients, impurities and immune reactions. CDC warns that unsafe injections can spread hepatitis and other infections. If you feel unwell after using one, call 911 in an emergency or Poison Help at 1-800-222-1222, and tell a clinician.
What does "research use only" mean?
A "research use only" label states the seller's intended use: laboratory research, not use in people or animals. It is not an approval, and it is not a safety finding. Research-grade peptides are laboratory reagents. They are not medicines and not a substitute for one.
The label also does not settle the legal question by itself. FDA judges a product's intended use from labeling, advertising and the circumstances of sale (21 CFR 201.128). FDA has warned sellers whose research-labeled products were "sold directly to consumers for human use with dosing instructions" (FDA, 2026). See what research use only means and FDA warning letters to peptide sellers.
Has FDA found research peptides safe for people?
No. When several peptides were nominated for pharmacy compounding, FDA reviewed what was known about them and published its concerns (FDA, 2026). For BPC-157, FDA wrote that it "lacks sufficient information to know whether the drug would cause harm" in humans. For MOTS-c and TB-500, FDA said it had found no human exposure data. For CJC-1295, it identified serious adverse events, including increased heart rate.
Our page on why research peptides have no dose sets these findings out compound by compound.
What risks do FDA and CDC describe?
Table 1 summarizes the main risks and who documented them. The sections below explain each one in plain terms.
Documented risks of using research or unapproved peptide products in people (checked November 17, 2026)
| Risk | What the source says | Source |
|---|---|---|
| Wrong or harmful contents | Illegally marketed drugs sold online could contain "the wrong ingredients or harmful ingredients" or "too little, too much or no active ingredient at all" | FDA, 2026 |
| Impurities and endotoxin | Semaglutide vials bought online without a prescription had low purity, and endotoxin was found in every sample | Ashraf et al., 2024 |
| Immune reactions | Compounded drugs containing BPC-157, TB-500, MOTS-c and other peptides "may pose risk for immunogenicity" | FDA, 2026 |
| Infection | Unsafe injections "can spread diseases like hepatitis C, hepatitis B, bacterial and fungal diseases" | CDC, 2024 |
| Dosing errors | Adverse events, some requiring hospitalization, after patients drew up more than prescribed from multiple-dose vials | FDA, 2024 |
| Sport sanctions | BPC-157, TB-500, CJC-1295, ipamorelin and other peptides are prohibited at all times | WADA, 2026 |
Wrong, impure or contaminated contents
A vial's label is only as good as the process behind it. FDA warns that illegally marketed drugs sold online may be counterfeit or hold the wrong amount of the right ingredient (FDA, 2026). It calls research-labeled GLP-1 products sold for human use "of unknown quality." A 2024 study tested semaglutide vials bought online without a prescription. Their content did not match the label and purity was far below the claim. Every sample contained endotoxin, a bacterial toxin (Ashraf et al., 2024).
Approved medicines meant to be sterile or pyrogen-free must be tested batch by batch under FDA's manufacturing rules (21 CFR 211.167). A research-use label makes no such promise. Our guide to endotoxin testing explains what that lab test measures.
Immune reactions
Immunogenicity means the immune system may react to a peptide or to impurities that come with it. FDA lists this as a concern for most of the peptides it reviewed, often citing "aggregation" and "peptide-related impurities" (FDA, 2026).
Infection
CDC says the reuse of needles or syringes and the misuse of medication vials are unsafe injection practices. It warns that unsafe injections can spread hepatitis C, hepatitis B, and bacterial and fungal diseases (CDC, 2024). That risk exists even before the question of what is in the vial.
Dosing errors
FDA has reported adverse events, some needing hospital care, linked to dosing errors with compounded semaglutide. Patients drew up too much from multiple-dose vials, and some clinicians miscalculated doses. FDA also pointed to confusion between units of measurement (FDA, 2024). Those errors happened with prescribed products that came with directions. Research material has no approved directions at all.
Drug testing and sport
WADA's 2026 Prohibited List names BPC-157 under S0, non-approved substances. It names CJC-1295, ipamorelin, sermorelin, tesamorelin and TB-500 under S2. All are "prohibited at all times," in and out of competition (WADA, 2026). Athletes should check any substance with their anti-doping organization. See peptides on the 2026 WADA list.
What should you do if something goes wrong?
- In an emergency, call 911. MedlinePlus advises calling your local emergency number, such as 911, after a harmful exposure (MedlinePlus, 2025).
- Call Poison Help at 1-800-222-1222. It is free and confidential, open 24 hours a day, 7 days a week, and the call does not need to be an emergency (MedlinePlus, 2025).
- Tell a clinician exactly what you used. Keep the product and its packaging so a doctor or pharmacist can see the label.
- Report it to FDA. MedWatch takes reports of serious reactions, product quality problems and product use errors. Report online or call 1-888-INFO-FDA (1-888-463-6332) and press 2 (FDA, 2025).
Where can you get legitimate care instead?
- A licensed clinician. A doctor, nurse practitioner or physician assistant can tell you whether an FDA-approved medicine fits your goal.
- Approved medicines. For approved peptide drugs, the dose comes from the label and a prescriber. See peptide medicine labels and semaglutide and tirzepatide dosage.
- Clinical trials. Registered trials on ClinicalTrials.gov are the lawful route to investigational drugs. See how to find a peptide clinical trial.
- Safe pharmacies. FDA's BeSafeRx program explains how to buy prescription medicine online safely.
Frequently asked questions about research peptide risks
Can research-use-only peptides be used in people?
No. They are labeled for laboratory research only, not for human or veterinary use, and none is FDA-approved for use in people.
What are the risks of injecting research peptides?
FDA and CDC describe unknown or wrong contents, impurities and endotoxin, immune reactions, infection and dosing errors. FDA also says it lacks the information to know whether several research peptides would cause harm.
How do you inject or take BPC-157?
We do not give injection or use instructions for BPC-157 or any peptide. BPC-157 is not an approved drug, and FDA says it lacks the information to know whether it would harm people.
How do I report a side effect or a bad product to the FDA?
Use FDA's MedWatch program online at contact.fda.gov/report-problem, or call 1-888-INFO-FDA (1-888-463-6332) and press 2. MedWatch accepts reports of serious reactions, quality problems and use errors.
What should I do if I feel unwell after using a peptide?
Call 911 in an emergency. Otherwise call Poison Help at 1-800-222-1222, which is free, confidential and open 24 hours a day, and tell a clinician what you used.
Do peptides show up on a drug test?
We do not discuss detection. What matters is status: WADA's 2026 list prohibits BPC-157, TB-500, CJC-1295, ipamorelin and other peptides at all times.
What to know now
- Research use only: a label for laboratory work, not a safety finding or permission for human use.
- FDA's view: for several research peptides, FDA lacks the information to know whether they would cause harm.
- Documented risks: wrong contents, impurities and endotoxin, immune reactions, infection and dosing errors.
- Sport: many peptides are prohibited at all times under WADA's 2026 list.
- Help: 911, Poison Help at 1-800-222-1222, a clinician, and FDA MedWatch.
What we're watching
New FDA safety communications and warning letters about research-labeled peptides, any FDA decision on peptides for the 503A bulks list, and WADA's 2027 Prohibited List.